EUCTR2008-003767-39-IT进行中（未招募）不适用
Concomitant radiochemotherapy with Tegafur and Mitomycin in locally advanced anal canal cancer: Dose Escalation Study. - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2009年5月25日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •histologic diagnosis of squamous anal canal carcinoma; >=T2 and/or N+, M0; HIV -; ECOG 0-1; normal hepatic and renal parameters;informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •previous radiotherapy on pelvis, previous chemotherapy; previous local surgical excisions;pregnancy
研究者
相似试验
进行中（未招募）
不适用
ow-doses radiotherapy and concomitant chemotherapy with pemetrexed in progression desease NSCLC: a dose-descalation phase II study - NDadvanced and/or metastatic NSCLCMedDRA version: 9.1Level: LLTClassification code 10059515Term: Non-small cell lung cancer metastaticEUCTR2008-003690-40-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
进行中（未招募）
不适用
Combined chemio-radioterapy regimen of 5-FU plus irinotecan followed by chemotherapy for the treatment of colorectal cancer with resectable metastases at diagnosis - NDEUCTR2007-004053-28-ITISTITUTO ONCOLOGICO VENETO
进行中（未招募）
不适用
RADIOCHEMIOTERAPIA CON TEMOZOLOMIDE CONCOMITANTE E ADIUVANTE NEL TRATTAMENTO DEI LINFOMI CEREBRALI PRIMITIVI DOPO METOTREXATE AD ALTE DOSI: STUDIO DI DOSE ESCALATION - NDprimary central nervous lymphomaMedDRA version: 9.1Level: HLGTClassification code 10025323Term: Lymphomas NECEUCTR2007-003254-28-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
进行中（未招募）
1 期
Feasibility of radiotherapy and concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinomaPancreatic cancer or distal cholangiocarcinomaEUCTR2004-001126-24-BEniversity Hospital Ghent30
进行中（未招募）
不适用
Radiation therapy and concurrent plus adjuvant Temsirolimus (CCI-779) versus chemo-irradiation with Temozolomide in newly diagnosed glioblastoma without methylation of the MGMT gene promoter – a randomized multicenter, open-label, Phase II studypatients with newly diagnosed glioblastoma (GBM) without methylation of the DNA-repair enzyme O6-methylguanin-DNA-methyltransferase (MGMT) gene promoterMedDRA version: 9.1Level: LLTClassification code 10006153Term: Brain tumorEUCTR2008-003003-31-NLEORTC Headquarters108